Clinical Trial: Study Designed to Assess the Efficacy and Safety of the Neurolyser XR After Marketing Approval

U.S., Nov. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07926581) titled 'Study Designed to Assess the Efficacy and Safety of the Neurolyser XR After Marketing Approval' on Oct. 16.

Brief Summary: The Neurolyser XR demonstrated positive outcomes in the clinical studies prior to obtaining CE marking, and well as in multiple pilot trials performed globally. This Post-Market Clinical Follow-up study is required to evaluate the safety and effectiveness of the Neurolyser XR under real-world conditions.

Study Start Date: Nov. 12

Study Type: OBSERVATIONAL

Condition: Lumbar Zygapophyseal Pain Low Back Pain Facet Joint Pain; Low Back Pain

Intervention: DEVICE: High Intensity Focused Ultrasound

Use of high i...